Synergy CHC Corp(SNYR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.52 | Insider Own | 87.9% | Shs Outstand | 11.3M | Perf Week | - |
| Market Cap | 0.00B | Forward P/E | 0.6 | EPS next Y | 178.95% | Insider Trans | - | Shs Float | 8.2M | Perf Month | -19.2% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | -0.01 | Inst Own | 12.1% | Short Float | 27.25% | Perf Quarter | -57.05% |
| Income | -0.02B | P/S | 0.05 | EPS this Y | -553.6% | Inst Trans | -36.18% | Short Ratio | 0.07 | Perf Half Y | -88.69% |
| Sales | 0.03B | P/B | - | EPS next 5Y | - | ROA | -142.7% | Short Interest | 2.23M | Perf YTD | -95.13% |
| Book/sh | -2.21 | P/C | 4.47 | EPS past 3/5Y | 69.66% -0.8% | ROE | 76.9% | 52W High | -96.94% ($2.96) | Perf Year | -95.98% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | -7.52% 0.7% | ROIC | -232.6% | 52W Low | 33.09% ($0.07) | Perf 3Y | -23.95% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -221.57% | Gross Margin | 65.4% | Volatility(W/M) | 104.62% 37.49% | Perf 5Y | -87.32% |
| Dividend TTM | - | EV/Sales | 1.04 | Sales Y/Y TTM | -17.53% | Oper. Margin | -39.6% | ATR (14) | 0.07 | Perf 10Y | -96.2% |
| Dividend Ex-Date | - | Quick Ratio | 0.2 | EPS Q/Q | -330% | Profit Margin | -57% | RSI (14) | 46.23 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.9 | Sales Q/Q | -32.9% | SMA20 | -16.92% ($0.11) | Beta | -1.54 | Target Price | $3.75 |
| Payout | - | Debt/Eq | - | Earnings | 2026/08/13 | SMA50 | -37.11% ($0.14) | Rel Volume | 0 | Prev Close | $0.09 |
| Employees | 28 | LT Debt/Eq | - | EPS/Sales Surpr. | -866.67% -34.09% | SMA200 | -89.12% ($0.83) | Avg Volume(3M) | 30.61M | Price | $0.09 |
| IPO | 2014/3/17 | Option/Short | No/Yes | Trades | 0 | Volume | - | Change | - |
🧠 Synergy CHC () is a small-cap consumer healthcare company that sells brain health supplements (FOCUSfactor) and lifestyle brand products (Flat Tummy) at the center of its consumer health and beauty lineup. It leverages both online channels and offline distribution, and is a micro-cap stock currently building growth momentum through the recent expansion of its functional beverage (FOCUSfactor Beverage) line.
Over the past 1 year, on the lower side
97% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
SNYR has weak earnings and a weak balance sheet
Of every $100 in sales, $39.60 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -553.6% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $5. Peers typically go for $277. Compared with its own 1-year average, it is 15% cheaper now.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -87.3%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Short interest is a burden
27.3% of the float is sold short.
Tap to view numbers
It ranks #11 of 11 in the industry
Based on market cap of $1M.
COSM#7 Cosmos Health Inc $23M PER - 
ACH#8 Accendra Health Inc $16M PER - 
YI#9 111 Inc ADR $16M PER - 
MEDS#10 DataMEDS AI Inc $10M PER - SNYR#11 Synergy CHC Corp $1M PER - 
FAQ
What kind of company is SNYR?
SNYR belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of SNYR?
The market cap of SNYR is approximately $1M, ranking 5,877 within its sector.
What is the 52-week high and low for SNYR?
SNYR has recorded a 52-week high of $2.96 and a low of $0.07.
